These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12379362)

  • 1. Catalytic antibodies in clinical and experimental pathology: human and mouse models.
    Ponomarenko NA; Durova OM; Vorobiev II; Aleksandrova ES; Telegin GB; Chamborant OG; Sidorik LL; Suchkov SV; Alekberova ZS; Gnuchev NV; Gabibov AG
    J Immunol Methods; 2002 Nov; 269(1-2):197-211. PubMed ID: 12379362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of different abzymes in autoimmune-prone MRL-lpr/lpr mice is associated with changes in colony formation of haematopoietic progenitors.
    Andryushkova AA; Kuznetsova IA; Bineva VN; Toporkova LB; Sakhno LV; Tikhonova MA; Chernykh ER; Orlovskaya IA; Nevinsky GA
    J Cell Mol Med; 2007; 11(3):531-51. PubMed ID: 17635644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody proteases: induction of catalytic response.
    Gabibov AG; Friboulet A; Thomas D; Demin AV; Ponomarenko NA; Vorobiev II; Pillet D; Paon M; Alexandrova ES; Telegin GB; Reshetnyak AV; Grigorieva OV; Gnuchev NV; Malishkin KA; Genkin DD
    Biochemistry (Mosc); 2002 Oct; 67(10):1168-79. PubMed ID: 12460115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-hydrolyzing antibodies from sera of autoimmune-prone MRL/MpJ-lpr mice.
    Dubrovskaya VV; Andryushkova AS; Kuznetsova IA; Toporkova LB; Buneva VN; Orlovskaya IA; Nevinsky GA
    Biochemistry (Mosc); 2003 Oct; 68(10):1081-8. PubMed ID: 14616078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleotide-hydrolyzing antibodies from the sera of autoimmune-prone MRL-lpr/lpr mice.
    Andryushkova AA; Kuznetsova IA; Orlovskaya IA; Buneva VN; Nevinsky GA
    Int Immunol; 2009 Aug; 21(8):935-45. PubMed ID: 19556305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of catalytic (DNA-hydrolyzing) and cytotoxic properties of anti-dna autoantibodies.
    Suchkov SV
    Bull Exp Biol Med; 2001 Apr; 131(4):353-5. PubMed ID: 11550025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel functional activities of anti-DNA autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases.
    Kozyr AV; Kolesnikov AV; Aleksandrova ES; Sashchenko LP; Gnuchev NV; Favorov PV; Kotelnikov MA; Iakhnina EI; Astsaturov IA; Prokaeva TB; Alekberova ZS; Suchkov SV; Gabibov AG
    Appl Biochem Biotechnol; 1998 Oct; 75(1):45-61. PubMed ID: 10214696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Achievements and prospects of clinical abzymology].
    Suchkov SV; Alekberova ZS; Paleev FN; Naumova TE; Misikov VK; Kriazheva ES; Ponomarenko NA; Gabivov AG
    Vestn Ross Akad Med Nauk; 2005; (9):38-43. PubMed ID: 16250330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrolysis of myelin basic protein by polyclonal catalytic IgGs from the sera of patients with multiple sclerosis.
    Polosukhina DI; Kanyshkova TG; Doronin BM; Tyshkevich OB; Buneva VN; Boiko AN; Gusev EI; Favorova OO; Nevinsky GA
    J Cell Mol Med; 2004; 8(3):359-68. PubMed ID: 15491511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Catalytic autoantibodies as a new molecular instrument in rheumatological practice].
    Khitrov AN; Mal'tsev KA; Vvedenskaia OIu; Ponomarenko NA; Isaeva MA; Kimova MV; Tret'iak EB; Shogenov ZS; Alekberova ZS; Gabibov AG; Suchkov SV
    Ter Arkh; 2006; 78(6):59-66. PubMed ID: 16881365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversity of DNA-hydrolyzing antibodies from the sera of autoimmune-prone MRL/MpJ-lpr mice.
    Kostrikina IA; Kolesova ME; Orlovskaya IA; Buneva VN; Nevinsky GA
    J Mol Recognit; 2011; 24(4):557-69. PubMed ID: 20842640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sites of the cleavage of 21- and 25-mer encephalytogenic oligopeptides corresponding to human myelin basic protein (MBP) by specific anti-MBP antibodies from patients with systemic lupus erythematosus.
    Timofeeva AM; Dmitrenok PS; Konenkova LP; Buneva VN; Nevinsky GA
    PLoS One; 2013; 8(3):e51600. PubMed ID: 23520443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity and catalytic heterogeneity and metal-dependence of polyclonal myelin basic protein-hydrolyzing IgGs from sera of patients with systemic lupus erythematosus.
    Bezuglova AM; Konenkova LP; Doronin BM; Buneva VN; Nevinsky GA
    J Mol Recognit; 2011; 24(6):960-74. PubMed ID: 22038803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of catalytic antibody repertoire in autoimmune mice.
    Nishi Y
    J Immunol Methods; 2002 Nov; 269(1-2):213-33. PubMed ID: 12379363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmunity and immune system dysregulation in schizophrenia: IgGs from sera of patients hydrolyze myelin basic protein.
    Parshukova D; Smirnova LP; Ermakov EA; Bokhan NA; Semke AV; Ivanova SA; Buneva VN; Nevinsky GA
    J Mol Recognit; 2019 Feb; 32(2):e2759. PubMed ID: 30112774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RhoB blockade selectively inhibits autoantibody production in autoimmune models of rheumatoid arthritis and lupus.
    Mandik-Nayak L; DuHadaway JB; Mulgrew J; Pigott E; Manley K; Sedano S; Prendergast GC; Laury-Kleintop LD
    Dis Model Mech; 2017 Nov; 10(11):1313-1322. PubMed ID: 28882929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope specificity of anti-HIV antibodies in human and murine autoimmune diseases.
    Fraziano M; Montesano C; Lombardi VR; Sammarco I; De Pisa F; Mattei M; Valesini G; Pittoni V; Colizzi V
    AIDS Res Hum Retroviruses; 1996 Apr; 12(6):491-6. PubMed ID: 8679304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mononuclear phagocyte system dysfunction in murine SLE: abnormal clearance kinetics precede clinical disease.
    Meryhew NL; Shaver C; Messner RP; Runquist OA
    J Lab Clin Med; 1991 Mar; 117(3):181-93. PubMed ID: 2002275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural antibodies that react with V-region peptide epitopes of DNA-binding antibodies are made by mice with systemic lupus erythematosus as disease develops.
    Ward FJ; Knies JE; Cunningham C; Harris WJ; Staines NA
    Immunology; 1997 Nov; 92(3):354-61. PubMed ID: 9486108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRL mice produce anti-Su autoantibody, a specificity associated with systemic lupus erythematosus.
    Treadwell EL; Cohen P; Williams D; O'Brien K; Volkman A; Eisenberg R
    J Immunol; 1993 Jan; 150(2):695-9. PubMed ID: 8419494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.